Squarepoint’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-627,926
Closed -$556K 4050
2022
Q4
$556K Buy
627,926
+577,082
+1,135% +$765K ﹤0.01% 2213
2022
Q3
$80K Buy
+50,844
New +$115K ﹤0.01% 2819
2022
Q2
Sell
-286,694
Closed -$668K 3648
2022
Q1
$668K Buy
+286,694
New +$894K 0.01% 1837
2021
Q4
Sell
-14,442
Closed -$110K 3668
2021
Q3
$110K Sell
14,442
-29,872
-67% -$253K ﹤0.01% 2648
2021
Q2
$429K Sell
44,314
-287,078
-87% -$2.29M ﹤0.01% 2256
2021
Q1
$2.74M Buy
331,392
+293,749
+780% +$3.1M 0.03% 907
2020
Q4
$257K Sell
37,643
-25,532
-40% -$205K ﹤0.01% 2332
2020
Q3
$704K Buy
63,175
+52,950
+518% +$485K 0.01% 1202
2020
Q2
$64K Sell
10,225
-31,775
-76% -$122K ﹤0.01% 2076
2020
Q1
$77K Sell
42,000
-119,262
-74% -$344K ﹤0.01% 1680
2019
Q4
$545K Buy
+161,262
New +$384K ﹤0.01% 1724
2017
Q3
Sell
-13,602
Closed -$27K 1966
2017
Q2
$27K Buy
+13,602
New +$26.5K ﹤0.01% 1483
2017
Q1
Sell
-16,116
Closed -$79K 2015
2016
Q4
$79K Buy
+16,116
New +$96.8K ﹤0.01% 1656

Other funds holding SRNE